Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Inhalte:

  • => Welche Forschungsthemen werden an der Medizinischen Universität bearbeitet?.
  • => Wer ist daran beteiligt und welche Methoden werden angewandt?.
  • => Welche Fördergeber unterstützen welche Projekte?.
  • => Wo werden Forschungsergebnisse publiziert?.

Facts and Figures: 2.652 Forscher*innenprofile (davon 1578 mit ORCID-ID), 8.528 Forschungsprojekte, 153.202 Publikationen, Posters und Vorträge, 63.428 Volltextlinks (davon Volltext frei zugänglich: > 27.762 (Open Access) )

Aktuelle Zitierungen im Web of Science: 1.930.043, davon 3.771 citation classics (>=100 Zitierungen) Summe Altmetrics Score: 294.997

Aktuell durch Fördergeber bewilligte Forschungsprojekte:

Anatomisches Erbe: Unseren Vergangenheit digital bewahren, Unsere Zukunft sichern
Projektleitung: Hammer Niels
Laufzeit: 01.06.2025 - 31.12.2026
Geldgeber: Österreichische Agentur für internationale Mobilität und Kooperation in Bildung, Wissenschaft und Forschung, OeAD GmbH (ÖAD)

Weiterentwicklung von genetisch codierten K+ Biosensoren
Projektleitung: Malli Roland
Laufzeit: 01.10.2025 - 30.09.2028
Geldgeber: FWF, Fonds zur Förderung der Wissenschaftlichen Forschung

> Weitere neue Projekte

Die aktuellsten Publikationen in "Top-Journalen" (Top 20 % Impact Ranking):


26.05.2025:

Strocchi, M; Samways, JW; Naraen, A; Ali, N; Shun-Shin, MJ; Gillette, K; Rinaldi, CA; Arnold, AD; Plank, G; Vigmond, EJ; Whinnett, Z; Niederer, SA An in silico guide for ventriculo-ventricular delay programming for left bundle branch-optimized cardiac resynchronization therapy
EUROPACE. 2025; 27(5): euaf089 Doi: 10.1093/europace/euaf089 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

26.05.2025:

Simic, M; Neuper, C; Hauer, R; Griessmair, K; Hill, C; Hohenester, U Optofluidic Force Induction: A Workbench for Nanoparticle Characterization and Material Analytics
NANO LETT. 2025; Doi: 10.1021/acs.nanolett.5c01126
Web of Science PubMed FullText FullText_MUG

 

26.05.2025:

van de Sande, MJA; Lopriore, E; Lanna, M; Ville, Y; Lewi, L; Weingertner, AS; Ryan, G; Otaño, L; Klaritsch, P; Blanco, AMB; Bevilacqua, E; Slaghekke, F; Tollenaar, LSA Single fetal demise in twin anemia-polycythemia sequence: perinatal outcome of surviving cotwin
ULTRASOUND OBST GYN. 2025; Doi: 10.1002/uog.29242
Web of Science PubMed FullText FullText_MUG

 

26.05.2025:

Schlager, O; De Carlo, M; Mazzolai, L; Bura-Riviere, A; Heiss, C; Palomares, JR; Morais, JCA; Steiner, S; Brodmann, M; Aboyans, V; De Caterina, R Antithrombotic treatment following revascularization for chronic limb-threatening ischaemia: a scientific statement of the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy
EUR HEART J. 2025; Doi: 10.1093/eurheartj/ehaf317
Web of Science PubMed FullText FullText_MUG

 

26.05.2025:

Ghallab, A; Mandorfer, M; Stirnimann, G; Geyer, J; Lindström, E; Luedde, T; van, der, Merwe, S; Rashidi-Alavijeh, J; Schmidt, H; Karpen, SJ; Fickert, P; Trauner, M; Hengstler, JG; Dawson, PA Enteronephrohepatic Circulation of Bile Acids and Therapeutic Potential of Systemic Bile Acid Transporter Inhibitors.
J Hepatol. 2025; Doi: 10.1016/j.jhep.2025.05.009
PubMed FullText FullText_MUG

 

26.05.2025:

Contieri, R; Martini, A; Beijert, IJ; Mertens, LS; Hentschel, AE; Bründl, J; Compérat, EM; Plass, K; Rodríguez, O; Subiela, Henríquez, JD; Hernández, V; de, la, Peña, E; Alemany, I; Turturica, D; Pisano, F; Soria, F; Čapoun, O; Bauerová, L; Pešl, M; Maxim, Bruins, H; Runneboom, W; Herdegen, S; Breyer, J; Brisuda, A; Calatrava, A; Rubio-Briones, J; Seles, M; Mannweiler, S; Bosschieter, J; Kusuma, VRM; Ashabere, D; Huebner, N; Seisen, T; Claps, F; Masson-Lecomte, A; Liedberg, F; Cohen, D; Lunelli, L; Cussenot, O; Sheikh, SE; Volanis, D; Côté, JF; Rouprêt, M; Haitel, A; Shariat, SF; Mostafid, AH; Nieuwenhuijzen, JA; Zigeuner, R; Dominguez-Escrig, JL; Hacek, J; Zlotta, AR; Burger, M; Evert, M; de, Kaa, CAH; van, der, Heijden, AG; Kiemeney, LALM; Soukup, V; Molinaro, L; Hurle, R; Paciotti, M; Moschini, M; Pradere, B; Perdonà, S; Gontero, P; Llorente, C; Algaba, F; Palou, J; N'Dow, J; Ribal, MJ; van, der, Kwast, TH; Babjuk, M; Sylvester, RJ; van, Rhijn, BWG Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder Cancer.
Eur Urol Oncol. 2025; Doi: 10.1016/j.euo.2025.04.010
PubMed FullText FullText_MUG

 

26.05.2025:

Haude, M; Wlodarczak, A; van, der, Schaaf, RJ; Torzewski, J; Ferdinande, B; Escaned, J; Iglesias, JF; Bennett, J; Toth, G; Joner, M; Toelg, R; Wiemer, M; Olivecrona, G; Vermeersch, P; Waksman, R Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study.
EuroIntervention. 2025; Doi: 10.4244/EIJ-D-25-00396
PubMed FullText FullText_MUG

 

26.05.2025:

Schebb, NH; Kampschulte, N; Hagn, G; Plitzko, K; Meckelmann, SW; Ghosh, S; Joshi, R; Kuligowski, J; Vuckovic, D; Botana, MT; Sánchez-Illana, Á; Zandkarimi, F; Das, A; Yang, J; Schmidt, L; Checa, A; Roche, HM; Armando, AM; Edin, ML; Lih, FB; Aristizabal-Henao, JJ; Miyamoto, S; Giuffrida, F; Moussaieff, A; Domingues, R; Rothe, M; Hinz, C; Das, US; Rund, KM; Taha, AY; Hofstetter, RK; Werner, M; Werz, O; Kahnt, AS; Bertrand-Michel, J; Le, Faouder, P; Gurke, R; Thomas, D; Torta, F; Milic, I; Dias, IHK; Spickett, CM; Biagini, D; Lomonaco, T; Idborg, H; Liu, JY; Fedorova, M; Ford, DA; Barden, A; Mori, TA; Kennedy, PD; Maxey, K; Ivanisevic, J; Gallart-Ayala, H; Gladine, C; Wenk, M; Galano, JM; Durand, T; Stark, KD; Barbas, C; Garscha, U; Gelhaus, SL; Ceglarek, U; Flamand, N; Griffin, JL; Ahrends, R; Arita, M; Zeldin, DC; Schopfer, FJ; Quehenberger, O; Julian, R; Nicolaou, A; Blair, IA; Murphy, MP; Hammock, BD; Freeman, B; Liebisch, G; Serhan, CN; Köfeler, HC; Jakobsson, PJ; Steinhilber, D; Gelb, MH; Holčapek, M; Andrew, R; Giera, M; FitzGerald, GA; Murphy, RC; Newman, JW; Dennis, EA; Ekroos, K; Milne, GL; Gijón, MA; Vesper, HW; Wheelock, CE; O'Donnell, VB Technical recommendations for analyzing oxylipins by liquid chromatography-mass spectrometry.
Sci Signal. 2025; 18(887):eadw1245 Doi: 10.1126/scisignal.adw1245
PubMed FullText FullText_MUG

 

26.05.2025:

Holzer, P Editorial: Pharmacological targets for the control of tissue remodelling and fibrosis.
Pharmacol Ther. 2025; 272:108880 Doi: 10.1016/j.pharmthera.2025.108880
PubMed FullText FullText_MUG

 

26.05.2025:

Pantel, K; Alix-Panabières, C; Hofman, P; Stoecklein, NH; Lu, YJ; Lianidou, E; Giacomini, P; Koch, C; de, Jager, V; Deans, ZC; Fairley, J; Patton, SJ; Toledo, RA; Schuuring, E; Heitzer, E; Hendrix, A; Ricklefs, FL; Thakur, BK; von, Bubnoff, N; Pierga, JY; Gebhardt, C; Andersen, CL; Fijneman, R; Malats, N; Hallermayr, A; Chelala, C; Joosse, SA; Ciliberto, G Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS).
J Exp Clin Cancer Res. 2025; 44(1):156 Doi: 10.1186/s13046-025-03398-4 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

26.05.2025:

Holzer-Stock, CS; Pukaluk, A; Viertler, C; Regitnig, P; Schweighofer, M; Eschbach, M; Caulk, AW; Holzapfel, GA A biomechanical comparative study of passive stomach tissue from pigs and humans.
Acta Biomater. 2025; Doi: 10.1016/j.actbio.2025.05.013
PubMed FullText FullText_MUG

 

26.05.2025:

Reiter, C; Reiter, G; Kolesnik, E; Scherr, D; Schmidt, A; Fuchsjäger, M; Reiter, U 4D flow MRI-based grading of left ventricular diastolic dysfunction: a validation study against echocardiography.
Eur Radiol. 2025; Doi: 10.1007/s00330-025-11703-0
PubMed FullText FullText_MUG

 

26.05.2025:

Fließer, E; Jandl, K; Chen, SH; Wang, MT; Schupp, JC; Kuebler, WM; Baker, AH; Kwapiszewska, G Transcriptional signatures of endothelial cells shape immune responses in cardiopulmonary health and disease.
JCI Insight. 2025; 10(10): Doi: 10.1172/jci.insight.191059
PubMed FullText FullText_MUG

 

26.05.2025:

Frederiksen, KS; Boada, M; Dubois, B; Engelborghs, S; Frisoni, GB; Georges, J; Hort, J; Jönsson, L; Kramberger, MG; Ousset, PJ; Scarmeas, N; Schmidt, R; Schott, JM; Spiro, L; Waldemar, G; Winblad, B; Jessen, F; Frölich, L Navigating the introduction of anti-amyloid therapy in Europe: a position statement by individual members of the EADC.
Alzheimers Res Ther. 2025; 17(1):116 Doi: 10.1186/s13195-025-01766-y
PubMed FullText FullText_MUG

 

24.05.2025:

Pfurtscheller, D; Schlatzer, C; Höller, N; Schwaberger, B; Mileder, LP; Baik-Schneditz, N; Pichler, G Newborn blood pressure dynamics during immediate postnatal transition - a retrospective analysis.
Ital J Pediatr. 2025; 51(1): 149 Doi: 10.1186/s13052-025-02001-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

> Weitere aktuelle Publikationen in Top-Journals

Distribution of Med Uni Graz affiliated publications by field-normalized Journal Impact Factor (JIFnorm)


Med Uni Graz publications1 were assigned quintiles according to the normalized2 Clarivate’s Journal Impact Factor of the journal at the time of publication.


Proportional Distribution: The color-coded columns show the distribution by JIFnorm-quintiles, while the left vertical axis indicates the proportion relative to the total articles published in a given year. The red line shows the total number of articles published each year (right vertical axis).


JIFnorm: Proportional Distribution


Example 1: Around 40% of the over 500 articles with Med Uni Graz affiliation published in 2019 had a normalized JIF > 0.8 (QU1).
Example 2: The proportion of articles published in journals with a normalized JIF < 0.4 (QU4 and QU5) has remained under 20% since 2010.

Absolute Impact: The sum of the normalized JIFs for all published articles in a given year, color-coded according to the respective quintile.


JIFnorm: Absolut Impact


1 This analysis considered only publications categorized as full papers/original articles.

2 IFnorm = (number of journals in WoS category - ranking of journal + 1) / number of journals in JCR SCIE/SSCI category. An IFnorm of 0.8 means that 20% of the journals in this subject category have a higher IF than the respective journal. The highest possible IFnorm is 1, which means that this journal currently has the highest IF in this subject category.

© Med Uni Graz Impressum